Terms: = Bone cancer AND TNFAIP3, TNFA1P2, 7128, ENSG00000118503, OTUD7C, MGC138687, MGC104522, A20, MGC138688, P21580 AND Treatment
10 results:
1. A non-small cell lung carcinoma patient responded to crizotinib therapy after alectinib-induced interstitial lung disease.
Sun W; Zheng J; Zhou J; Zhou J
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2023 Oct; 52(5):583-587. PubMed ID: 37899398
[TBL] [Abstract] [Full Text] [Related]
2. Clinicopathologic and mutational profiles of primary breast diffuse large B cell lymphoma in a male patient: case report and literature review.
Huang F; Ruan Y; He X; Lian H; Yang J
World J Surg Oncol; 2023 Oct; 21(1):342. PubMed ID: 37884941
[TBL] [Abstract] [Full Text] [Related]
3. Clinical and molecular characteristics of lymphoplasmacytic lymphoma not associated with an IgM monoclonal protein: A multicentric study of the Rete Ematologica Lombarda (REL) network.
Varettoni M; Boveri E; Zibellini S; Tedeschi A; Candido C; Ferretti VV; Rizzo E; Doni E; Merli M; Farina L; Goldaniga M; Gallì A; Rattotti S; Frustaci AM; Deodato M; Bandiera L; Isimbaldi G; Uccella S; Cabras AD; Gianelli U; Baldini L; Paulli M; Arcaini L
Am J Hematol; 2019 Nov; 94(11):1193-1199. PubMed ID: 31378966
[TBL] [Abstract] [Full Text] [Related]
4. E-cadherin expression on multiple myeloma cells activates tumor-promoting properties in plasmacytoid DCs.
Bi E; Li R; Bover LC; Li H; Su P; Ma X; Huang C; Wang Q; Liu L; Yang M; Lin Z; Qian J; Fu W; Liu YJ; Yi Q
J Clin Invest; 2018 Nov; 128(11):4821-4831. PubMed ID: 30277474
[TBL] [Abstract] [Full Text] [Related]
5. Pattern of somatic mutations in patients with Waldenström macroglobulinemia or IgM monoclonal gammopathy of undetermined significance.
Varettoni M; Zibellini S; Defrancesco I; Ferretti VV; Rizzo E; Malcovati L; Gallì A; Porta MGD; Boveri E; Arcaini L; Candido C; Paulli M; Cazzola M
Haematologica; 2017 Dec; 102(12):2077-2085. PubMed ID: 28983055
[TBL] [Abstract] [Full Text] [Related]
6. Evaluation of the germline single nucleotide polymorphism rs583522 in the tnfaip3 gene as a prognostic marker in esophageal cancer.
Ghadban T; Schmidt-Yang M; Uzunoglu FG; Perez DR; El Gammal AT; Miro JT; Wellner U; Pantel K; Izbicki JR; Vashist YK
Cancer Genet; 2015 Dec; 208(12):595-601. PubMed ID: 26598072
[TBL] [Abstract] [Full Text] [Related]
7. Novel ligands for cancer diagnosis: selection of peptide ligands for identification and isolation of B-cell lymphomas.
McGuire MJ; Samli KN; Chang YC; Brown KC
Exp Hematol; 2006 Apr; 34(4):443-52. PubMed ID: 16569591
[TBL] [Abstract] [Full Text] [Related]
8. The natural history of a novel, systemic, disseminated model of syngeneic mouse B-cell lymphoma.
Passineau MJ; Siegal GP; Everts M; Pereboev A; Jhala D; Wang M; Zhu ZB; Park SK; Curiel DT; Nelson GM
Leuk Lymphoma; 2005 Nov; 46(11):1627-1638. PubMed ID: 16334907
[TBL] [Abstract] [Full Text] [Related]
9. Induction of cytotoxic T-cell responses against the oncofetal antigen-immature laminin receptor for the treatment of hematologic malignancies.
Siegel S; Wagner A; Kabelitz D; Marget M; Coggin J; Barsoum A; Rohrer J; Schmitz N; Zeis M
Blood; 2003 Dec; 102(13):4416-23. PubMed ID: 12869512
[TBL] [Abstract] [Full Text] [Related]
10. A summary of two clinical studies on tumor cell dissemination in primary and metastatic breast cancer: methods, prognostic significance and implication for alternative treatment protocols (Review).
Kasimir-Bauer S; Oberhoff C; Schindler AE; Seeber S
Int J Oncol; 2002 May; 20(5):1027-34. PubMed ID: 11956600
[TBL] [Abstract] [Full Text] [Related]
